Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
- Study Title
- Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine
- Teva Identifier
- GA 9015
- ClinicalTrials.gov Identifier
- NCT00203099
- Study Status
- Completed
- Trial Condition(s)
- Relapse Remitting Multiple Sclerosis
- Interventions
- Drug: Glatiramer Acetate, N-Acetylcysteine
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult
- Age Range
- 18 Years to 50 Years
- Trial Duration
- 12/01/2004 - 06/01/2008
- Phase
- Phase 2
